Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lord

Showing results (41-50 of 593) with videos related to

Pageof 60
Sort By:
Nature|January 20, 2012
The DNA damage response and cancer therapyChristopher J Lord, Alan Ashworth
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|February 1, 1991
Chemotherapy for glioblastoma multiformeJ Lord, E A Coleman
The Anatomical Record|March 27, 2010
Brain-modelling as a method for teaching advanced neuroanatomyF L McNAUGHTON, J LORD
Science (New York, N.Y.)|March 18, 2017
PARP inhibitors: Synthetic lethality in the clinicChristopher J Lord, Alan Ashworth
Nature Medicine|November 9, 2013
Mechanisms of resistance to therapies targeting BRCA-mutant cancersChristopher J Lord, Alan Ashworth
Proceedings. Mathematical, Physical, and Engineering Sciences|February 10, 2015
Basis properties of the <i>p</i>, <i>q</i>-sine functionsLyonell Boulton, Gabriel J Lord
Canadian Medical Association Journal|May 15, 1984
[Sterility of immunologic origin]X De Muylder, J Lord
Anesthesiology|June 1, 1980
Contamination of an anesthesia system with liquid halothaneB L Zimmerman, J Lord
Nature Structural & Molecular Biology|June 6, 2007
RAD51, BRCA2 and DNA repair: a partial resolutionChristopher J Lord, Alan Ashworth
Nature Reviews. Clinical Oncology|June 30, 2018
Synthetic lethal therapies for cancer: what's next after PARP inhibitors?Alan Ashworth, Christopher J Lord
Pageof 60

Showing results (41-50 of 593) with videos related to

Sort By:
Pageof 60
Nature|January 20, 2012
The DNA damage response and cancer therapyChristopher J Lord, Alan Ashworth
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|February 1, 1991
Chemotherapy for glioblastoma multiformeJ Lord, E A Coleman
The Anatomical Record|March 27, 2010
Brain-modelling as a method for teaching advanced neuroanatomyF L McNAUGHTON, J LORD
Science (New York, N.Y.)|March 18, 2017
PARP inhibitors: Synthetic lethality in the clinicChristopher J Lord, Alan Ashworth
Nature Medicine|November 9, 2013
Mechanisms of resistance to therapies targeting BRCA-mutant cancersChristopher J Lord, Alan Ashworth
Proceedings. Mathematical, Physical, and Engineering Sciences|February 10, 2015
Basis properties of the <i>p</i>, <i>q</i>-sine functionsLyonell Boulton, Gabriel J Lord
Canadian Medical Association Journal|May 15, 1984
[Sterility of immunologic origin]X De Muylder, J Lord
Anesthesiology|June 1, 1980
Contamination of an anesthesia system with liquid halothaneB L Zimmerman, J Lord
Nature Structural & Molecular Biology|June 6, 2007
RAD51, BRCA2 and DNA repair: a partial resolutionChristopher J Lord, Alan Ashworth
Nature Reviews. Clinical Oncology|June 30, 2018
Synthetic lethal therapies for cancer: what's next after PARP inhibitors?Alan Ashworth, Christopher J Lord
Pageof 60